Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Derma enters phase II development for wound-healing product

Jan. 30, 2008

Tripep and Kringle Pharma apply for permission to initiate phase II study of ChronSeal

Jan. 23, 2008

Argyll successfully completes first phase of formal proof of concept trial for SF-1019

Jan. 23, 2008

New treatment option for psoriasis imparted in recent Nippon Shinyaku patent

Jan. 22, 2008

FDA approves Abbott's Humira for moderate to severe chronic plaque psoriasis

Jan. 21, 2008

Synvista and Novel Therapeutic Technologies enter agreement for ALT-2074 for psoriasis

Jan. 21, 2008

Biofrontera initiates phase III BF-200 ALA trial in actinic keratosis

Jan. 16, 2008

CollaGenex initiates phase II clinical trial of vitamin D analogue becocalcidiol for psoriasis

Jan. 15, 2008

ASF-1096 investigated in discoid and subacute lupus erythematosus

Jan. 4, 2008

Basilea files Canadian New Drug Submission for alitretinoin for chronic hand eczema

Dec. 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...